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ABSTRACT
The teratogenic potential of Sodium Dodecylbenzene
Sulfonate, a biodegradable anionic surfactant, has been
investigated in the ICR CD-1 strain of mice.

Levels at

which nonnal blastocyst implantation would occur were determined by the oral administration of a LAS-distilled, deionized water suspension to 3 to 5 month old pregnant females,
from day 0 to 7 of gestation.

Doses ranged from 0 to 300

mg/kg at 25 mg/kg increments.

The highest dosage level at

which the number of blastocyst implants equalled that of
controls was 225 mg/kg.
In a subsequent 17 day study, doses of 225, 100, 5,
and 0 mg/kg LAS were administered orally by intubation to
2~

month old pregnant females.

No significant visceral

defects or skeletal anomalies were observed at the gross
level.

The increased number of fetal deaths and resorptions

observed suggests that embryotoxicity was evident after
early exposure of the embryo to the surfactant.
compared with mammalian studies

~n

Results are

which mode and timing

of administration, as well as species tolerance, significantly affected the type of results which were observed.
Human teratogenic potential appears moot, since relatively high concentrations of the surfactant were required
iv

~-

to produce deleterious effects.
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INTRODUCTION
Linear alkylbenzene sulfonate (LAS) is a biodegradable, anionic surfactant commonly used in
gents (Swisher, 1970; Harris et

~·,

commer~ial

1971).

deter-

Becaus.e it is

a synthetic surfactant, studies of its effects upon vertebrates, particularly mammals, have been undertaken to determine toxic and/or teratogenic levels.· The question o.f
its teratogenic potential is quite complex, and has led to
conflicting conclusions.
Teratology, according to Webster's Dictionary, is
"the scientific study of biological monstrosities and malformations."

These malformations are normally produced dur-

ing development.

Thus, compounds that would ordinarily be

relatively harmless to adults,

may have deleterious effects

on developing organisms because the fetu'S lacks the detoxifying capabilities of adults (DiPaolo, 1969).

J:Iowever,

limitations arise in subsequent testing due to species tolerance.

Past studies have shown that not all vertebrates,

or even mammals, are equally susceptible to a teratogen.
A good example.is the thalidomide incident of the 1960•s.
Although initial testing showed that thalidomide did not
harm fetal mice and rats, it was teratogenic to humans
(Lenz, 1966).

Thus,

conclusi~ns

drawn from animal testing

2

are somewhat uncertain when compared with humans; no specific protocol for such tests can be outlined

(Brent~

1972).

A number of species must, therefore, be tested (Wilson,

1973).
Before considering the development of this environmental problem, a brief description of the surfactant and
its properties is necessary.

Surfactants, or surface active

agents, are arnphipathic molecules characterized by a polar,
hydrophilic, and a non-polar, hydrophobic portion.

Because

of the dual nature of such a molecule, surfactants are able
to lower surface energy along ari interface.
sifying agents and hence are found in most
(Haney

~

al., 1954).

They are emulcle~ing

agents

Surfactants are divided into three

types: anionic, nonionic, and

cationic~

The character of

the polar group determines the class to which the specific
molecule belongs.

Linear alkylbenzene sulfonate is anionic

due to the negative charge of its sulfonate group.

The non-

polar portion of the molecule consists of an alkyl chain attached to a benzene ring.
The nature of the alkyl group varies greatly in commercial surfactants, and significantly influences its chemical and biological action (Swisher, i963; Amend~, 1967).
The majority of alkylbenzene sulfonates (ABS) used before
1965 contained a tetrapropylene group as the alkyl chain
(Swisher, 1970).

..

_
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Due to the branching of the carbon skeleton, this compound
was difficult for sewage bacteria to breakdown (Sw'isher,
1963).

This unfavorable property of ABS prompted its re-

placement by a more biodegradable substance, LAS.
Conversion to .LAS occurred in the middle Sixties,
since LAS had been found to be more easily degraded by bacteria.

One study performed by Halvorson and Isaque (1968)

showed that 93% of a commercial preparation and 97.5% of an
11.3 preparation ' of LAS (an isomeric mixture containing an
average carbon chain length of 11.3) were metabolized into
non-detectable units by bacteria within 96 hours.

In a

similar study of the bacterial metabolism of dodecyl- and
undecylbenzene-p-sulfonate, Willetts and. Cain (1972)

pro~

posed a cleavage of the alkyl chain and the sulfonate group
from the phenyl ring, with their subsequent metabolism into
normal waste products.

According to this scheme,_ the sul-

fite is oxidized to sulfate, the alkyl chain undergoes betaoxidation, and the benzene ring is oxidized to succinate and
acetyl CoA (Figure 1).
Ideally, LAS is dodecylbenzene sulfonate, but cornmer-

4

Bacterial degradation scheme of LAS according
to Willetts and Cain (1972).

4

Figure 1
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cially prepared LAS characteristically represents a mixture

5

of straight chain carbon atoms ranging in number from 8 to
16.

The majority of position isomers are secondary, with

the benzene ring attached to the second carbon atom of the
alkyl chain.

(LAS)
The position of the phenyl ring and the chain length
of the alkyl group can alter the detergency and biodegradability of the compound (Rubinfeld et al., 1964; McAteer and
Kinnard, 1967).
known.

The mechanism of detergency is not well

Certainly micellar fonnation and solubilization are

key processes in detergency, but opinions differ with respect to the type of micellar organization and the energy
requirements for that ronnation (Anacker, 1970).
Biodegradability in mammals was established by
Michael (1968), who followed 35 s-LAS in albino rats.

His

results showed that 92% of the label was excreted into the
urine within 48 hours, while 35s-ABS accumulated in the ·
liver and was excreted in the feces.

Michael also establish-

ed that both LAS and ABS were absorbed through the gastrointestinal tract and were probably transported by the venous
blood.

The extent to which LAS had been degraded was deter-

_...
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mined by Nuclear Magnetic Resonance ( Nr-.1R) and showed that
60-65~

of the LAS excreted in the urine after 72 hours was

sulf ophenyl butanoic acid and sulfophenyl pentanoic acid.
These two compounds suggest omega- followed by beta-oxidation.

Thus, the LAS molecule is relatively intact in the

mammal, and if toxic or teratogenic effects are fowid, they
can be attributed to either the intact molecule or one of
its early degradation ·products.
The toxicity research with respect tef LAS is most
abundant for fish. Swisher (1964) detennined the toxicity of
dodecyl- and undecylbenzene-p-sulfonate to fish and showed
that the 12 carbon chain had a 4g hour TLtn (Median Tolerance
Limit) of J.O ppm, while the 11 carbon chain was 75 ppm.

A

more refined t.est of toxicity and structure was reported by
Hirsch (1963) who tested various structural isomers on the
fish, Goldorfen, ---:--Idus -idus.
....

His results showed that greater

toxicity as evidenced by lower TLm 's was obtained as the
chain length increased and the position·of the phenyl ring
crone closer to the primary carbon.

Similar results of the

higher toxicity of a primary 12 carbon isomer of LAS have
been reported in other species of fish (Borstlap, 1967).
The work of Manner and Dewese ( 1974) has demonstrated that
various mixtures of isomers differ in toxicity; a LAS preparation having an average carbon length of 11.8 was more
toxic than one having a carbon length of 11.2.

Although

these results suggest an environmental hazard on the part of

__

..

r

these compounds, the hazard may not be relevant to mai"unals,

7

since the manner of mammalian exposure to LAS is not the
sa~e

as fish.

Exposure to a developing mammal is only

through the circulatory system of the mother.

To achieve

this, the·mother must ingest the LAS or the material must be
absorbed through the skin.

The effects of LAS absorbed

through the skin cannot be discounted, but the amount absorbed in relation to other modes of entry is minimal (Gale,
1974).
Two sources of oral exposure to the surfactant are
possible: one from residual amounts in fresh water supplies,
the other rrom inadequately rinsed dishes after washing.
The United States Government has set allowable levels of LAS
in waterways at 0.5 ppm {'Swisher, 1970).

Tests of the

Calumet' River conducted by the Federal Water Pollution
Control Administratiori during ·1966 snowed an average Methylene Blue Active

.$ubst,a,nc~

The reaction between

(MEAS) of approximately 0.5 ppm •.

Methyl~ne

Blue and the anionic surfact-

ant involves a colorimetric assay or the salt fanned from
the two substances ( &'lfisher, 1970).

The value obtained from

this test agrees with :f'igures of MBAS obtained rrom the
Illinois River (Sullivan and Evans, 1968; Sullivan and
Swisher, 1969), the bulk of which represents LAS (Rickert
and Hunter, 197J).
Residual

&~cunts

of LAS left on improperly rinsed

dishes and glassware depend upon a number of factors.

A

_...

variety of reports have listed different figures for the
average human intake, with a reliable estimate being from
0.3 to 3.0 mg/person/day (Swisher, 1968).

For a 60 kg per-

son, this means a maximal daily dose of 0.05 mg/kg.

Never-

theless, individual amounts ingested may vary greatly, and
ma1l!llalian studies to determine the oral toxicity of LAS have
been performed.

Experimentation on rats is extensive, per-

haps because they are hardy animals and are large enough for
easy biochemical assay.

Bornmann and Loeser (1963) mixed

LAS into the drinking water of rats and found no apparent
ill effects.

Both male and female rats were given 100 ppm

LAS ad libitum for a period of lOO·weeks; subsequent autopsies showed no significant difference from controls with
respect to organ weights.

Similar.results have been obtain-

ed with dietary levels of LAS.
tions of 0.02, 0.1, and

-

0.5~

In these cases, concentra-

LAS were mixed with commercial

food and given ad libitum.to rats (Paynter and Weir, 1960;
Kay et al., 1965).

.

Even the administration by intubation of

commercial detergents containing 20fo LAS have not shown significant toxicity (Snyder et al., 1964).

.

study of the effects of 0.02, 0.1, and

An additional

0.5~

dietary LAS upon

rat reproduction demonstrated no significant differences
from controls through the F1 and F 2 generations. (Buehler et
al., 1971).
Toxicological and teratological studies of LAS on
mice have produced conflicting results.

In 1949, Hopper

_...

et al., using an early preparation of LAS designated

9

Santomerse No. 3, found that the oral Ln 50 was 2000 mg/kg in
mice, as opposed to the 650 mg/kg established by Oser and
Morgareidge (1965) in rats.

Recently, Mikami et al. (1973)

administered 60 mg/kg of LAS in the drinking water of pregnant ICR mice, and reported that litters exhibit.ed onethird to one-half cleft palate, a small percentage of exencephaly and microphthalmia, and one-third to one half fetal death.

Another report, by Sakai (1973} of the Mikami

group, stated that concentrations of as low as 0.015 mg/kg
LAS produced cleft palate, spina bifida, and anencephaly in
a percutaneous study on ICR/JCL mice.

However, Palmer et al.

(1973} also applied LAS to the skin of ICR CD-1 mice in concentrations of 0.03, 0.3, and 3.0%.

He found that at 3.0%,

an 80% implantation loss occurred.along with a decrease in
normal weight gains during pregnancy.

Minor skeletal var-

iations were the most cormnon abnormality, but they were
within "laboratory limits".

A more recent work by Pelmer

et al. (1975) reported that no teratogenesis was evident in
CD-1 mice that had been given 0.2, 2.0, 300, and 600 mg/kg
of LAS by intubation from days 6 to 15 of gestation •. However, maternal toxicity was evident at the 600 and 300 mg/kg
doses.
Although these results appear conclusive with respect
to the teratogenic potential of LAS, the basis for the retesting of LAS in mammalian systems is based upon several

r
10

recent findings.

Manner and Dewese (1974) demonstrated

that an 11.8 LAS preparation produced neural anomalies in
Zebra fish, Brachydanio rerio, at concentrations of less
than 5 ppm.

Curvature of the spine, anophthalmia, micr-

ophthalmia, and even deaths were observed when the embryo
had been exposed at the late cleavage stage of development.
These results were consistent with those of Mikami et al.

( 1973), who had reported that 60 mg/kg of orally administered LAS produced exencephaly, microphthalmia, cleft palate,
and even fetal death in ICR/JCL mice.

The previously des_..

cribed results had not been reported in fish, mice, or rats.
Palmer~~·

(1975), in reassessing the teratogenic pot-

ential of LAS upon mice, rats, and rabbits, found the rat
to be more tolerant of the surfactant than other species.
Since generalizations regarding lack of teratogenesis of LAS
toward rats had been projected to include all mammals,· there
is now doubt regarding the validity of such a conclusion.
Further, the procedure employed by Palmer had been to dose
the animals after blastocyst implantation.

The teratogenic

potential of LAS administered during early mammalian embryonic development had been overlooked.

Manner and Dewese

(1974) had shown that this period was most susceptible to
LAS teratogenicity in fish embryos.

Thus, their observa-

tions, suggesting early stages of embryogenesis are most
susceptible to LAS teratogenicity, form a working hypothesis
to be tested in mammals.

--

MATERIALS AND METHODS
Two basic differences from the majority of toxicological work done with LAS were employed here.

First, the

mode of administration, intubation, is used infrequently except for the detennination of Lo 50 values; however, it provides a more accurate record of the amount of material which
the animal has received.

Second, ch.ronic or prolonged doses

were used instead of dividing the gestation period into sections and administering the dose only at specific times

--

(King et al., 1972).
'

The amount of time. available to study

a given number of animals was the limiting factor of this
method.
One ambiguity of teratology is

th~

tween physic.al and functional anomalies.

distinction beIn the examina-

tion of fetuses, only physical defects were considered,
since functional deviations often take time to verify, a
process which can take place only if the fetuses are living.
General Procedures
Forty-two day old virgin ICR CD-1 mice were obtained
from the Charles River Breeding Laboratory, Wilmington,
Massachusetts, and allowed to mature to
before experimentation.

2~

months of age

Throughout the study, two to four

animals were housed in plastic shoe-box type cages
11

(6~

x 11

~-

. ®12
in.) containing an inert bedding material called Sanicel ~.
Purina Mouse Chow for Breeding Mice

® and

tap water were

given ad libitum, with distilled, deionized water being substituted for tap water during experimentation.

Fresh water

was provided every other day; water bottles and cages were
cleaned weekly.

A mild Alconox ® solution was employed dur-

ing cleaning, followed by 6-10 rinses under running tap
water.

Temperature was regulated at 22 ± i

±

hour cycle and a relative humidity of 50

0

c

under a 12

10%.

Females were exposed to males overnight in a ratio of

3-4 to 1.

Presence of vaginal plugs or sperm in vaginal

smears were taken as indications of fertilization and this
day was designated day 0 of gestation.

Pregnant mice used

for experimentation were separated from stock females and
grouped according to dose.
Sodill\~

dodecylbenzene sulfonate having an average

carbon length of 11.e was provided by the Procter and Gamble
Co., Cincinnati, Ohio.

The test material was an off-white

paste whose composition was assayed as 57.5% active· sodium
dodecylbenzene sulfonate, 2-3% unreacted alkylbenzene, 0.91%
sodium sulfate, and a remaining fraction of water.

A cor-

rection factor of 1.74 was used in calculating doses to adjust to 100% activity.

The test

~aterial

was refrigerated

to maintain consistency, but was allowed to come to room
temperature before weighing.

Since small amounts were

needed, a factor of 10 was employed to insure accuracy to
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within 0.5 mg; the volume of distilled, deionized water 11;as
also adjusted by a factor of 10.

Concentrations of LAS ad-

ministered were in relation to body weight to allow comparison with other species; all amounts varied according to the
daily weight changes of the animal.

Vials used for weighing

were thoroughly rinsed and dried beforehand; suspensions
were mixed with a teflon stir;ri.ng bar.

A gavage needle was

fanned from a 17 gauge needle by making a small bend at the
open end and attaching a ball of lead solder.

The needle

was thoroughly rinsed before and after each intubation, and
a fresh. plastic 1 cc syringe was used each day.

Single,

daily doses were administered at.12:00 P.M. + 2 hours.
All animals were killed by excess etherization, the
uteri excised, fetuses checked for movement, and uteri plus
contents weighed; indj_ vidual fetal weights were not taken.
Two-thirds

o~

the fetuses from each litter were placed into

vials containing Bouin's solution and allowed to f'ix for a
period of at least 10 days.

One-third of the fetuses were

placed into 95% ethanol, cleared, and stained with Alizarin
Red S according to Knudsen (1966).
Seventeen day old fetuses which had been preserved in
Bouin's fluid were sectioned according to Wilson (1965).
This method is used for gross examination; histologic variations were not considered.

Fetuses were examined for syn-

dactyly, polydactyly, adactyly, micromelia, phocomelia,
spina bifida, anophthalmia, microphthalmia, hydrocephaly,

..

_
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anencephaly, exencephaly, cleft palate, incomplete closure
of the ventricular

ca~diac

septum, diaphramatic hernia,

umbilical hernia, position of the aortic arch, number and
position of the kidneys and adrenal glands, and the presence
of gonads.

In addition, the volume of each fetus without

umbilicus was measured by water displacement as an indication of relative size.

Fetuses stained with Alizarin Red S

were examined for number of ribs, cervical vertebrae, sternal vertebrae, digits,. ossification of vertebrae centrae, and
general skeletal anomalies.
Range Study
Early in the research it had become apparent that the
high dose of 300 mg LAS/kg maternal body wei,ght was interfering with nonnal gestation.

A range of doses was there-

fore tested to detennine at what level implantation would
occur.

Pregnant females were randomly divided into groups

and administered 0.25 ml of a LAS-distilled, deionized water
suspension by intubation on a daily basis from day
gestation.

9

to 7 of

Doses from JOO to 100 mg/kg at 25 mg/kg incre-

ments were used with the addition of a 50 and 0 mg/kg dose
to complete the spectrum of doses.·

Control~

received 0.25

ml of the vehicle without LAS.
Females were killed on day 8 of gestation and the
number of implants recorded.

A minimum of three mice either

bearing or lacking implants was taken as sufficient indication of toxicity for each dose.

Sectioning of embryos was

15
not possible due to small embryonic sizes at this early
stage of development.
Term Study
Pregnant females were randomly distributed into
groups receiving 225, 100, and 5 mg LAS/kg body weight and
controls.

The teratogenic activity of JOO mg/kg of sodium

sulfate was also tested in a preliminary study upon 5 dams;
the results showed no significant abnormalities when compared with controls (Table I).

This dose was chosen to com-

pare the effects of sodium sulfate with an equal concentration of LAS.

Also, since only

0.91~

of the LAS preparation

was sodium sulfate, the level administered in the dose is
well below the lowest normal sulfate concentration in the
blood (Guyton, 1971).

Sodium sulfate was then minimized as

a teratogenic possibility.
All mice were placed into cages with animals receiving the same dose level.

Experimentals received 0.20 ml

LAS-distilled, deionized water suspension, while controls
received 0.20 ml distilled, deionized water.
gavaged for 17 days beginning on day
of gestation.

o,

Animals were

and killed on day 17

Fetuses were scored, placed in appropriate

solutions, and examined in the manner outlined previously.
Records were kept of the anomalies and resorptions found in
each litter.

The Kruskal-Wallis test, Wilcoxon Rank test,

and the Chi square test were used to ascertain statistical

~-

16
significance of the results (Sokal and Rohlf, 1969).
para~etric

Non-

values such as litter data are particularly

suited to the Kruskal-Wallis and Wilcoxon tests, while Chi
square is a well established test of frequencies.

--

RESULTS
Table I shows the results of oral administration of
300 mg sod:lum sulfate/kg body weight.

The observation of

one fetus with cleft palate does not appear to be teratogenically significant, since cleft palate is the most common sporadic visceral defect with a high incidence in this
strain of mice (Palmer, 1972).
Table II presents the results of the range study.

It

can be seen that of the concentrations of LAS used, 225 mg/kg
was the upper limit of surfactant which allowed the number
of implantations of blastocysts of experimentals to approximate that of the controls at almost every dose level below
225 mg/kg.

Because of borderline maternal toxicity at 200

and 225 mg/kg, more than 3 experimental animals were required to ascertain toxicity.

Dams receiving concentrations of
~·

250, 275, and 300 mg/kg failed to exhibit implantation of
blastocysts.

Maternal toxicity rather than embryotoxicity

is believed to have caused interference with the nonnal processes involved in fe,."'tilization and development leading to
implantation, since the usual $igns of maternal

~oxicity

such as weight loss and diarrhea were evident.

Since 225

mg/kg was the highest tolerable dose, it was used as the
17

..

._,,,,,...

TABLE I
RESULTS OF ADMINISTRATION OF 300 mg Na2so /kg BODY WEIGHT
4
NUMBER OF
LITTERS

LITTER
SIZE
± S.D.

PERCENTAGE
RESORBED AND
DEAD FETUSES
+ S.D.

LITTER WEIGHT
(gm) ± S.D.

3*

13.0+0.7

2.8+4.8

2***

11.0+l.O

0

* Pregnancies terminated on day

NUMBER OF
FETUSES
EXAMINED

NUMBER OF
FETUSES
AFFECTED

21.63±2.7

39

l**

5.57+1.1

22

0

18 of gestation.

of gestation.
** Fetus exhibited cleft palate.
*** Pregnaneies terminated on day 13 of gestation.
12 of ge9tation.

Animals dosed from day 0 to 17
Animals dosed from day 0 to

~

();).

I

\

·~

TABLE II
RANGE STUDY: LEVELS OF LAS AFFECTING NUMBER OF IMPLANTS
DOSE (mg/kg)

0

50

100

125

150

175

200

225

SAMPLE SIZE

9

4

4

3

4

3

6

5

12.4

13.3
+0.6

12.3
+2.S

13

15

+2.0

+l.O

14.6
+1.2

15
+1.0

11
+2.6

1

1

3

2

AVERAGE IMPLANTS
OF VIABLE LITTERS

+ S.D.

NUMBER NOT
PREGNANT

±3.3
1

0

1

-

0

Presented are the results of the range study in which dams received 0.25 ml LASvehicle from day 0 to 7 of gestation. These results show the average number of
implants observed on day 8. The "number not pregnant" is the number of confinned
matings which on examination did not bear blastocyst implants. The "sample size"
represents all confirmed matings.

I-'
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highest dose in the 17 day study; 100 mg/kg represented
the mid-region of the range; and 5 mg/kg was a close approximation of the amount of normal intake (Swisher, 1968).
Experimental parameters are summarized in Table III, and
include values for litter size, in utero litter weight,
fetal volume, and the percentage of dead and resorbed
fetuses of viable litters.

As can be seen, the litter

sizes and weights, as well as fetal volumes, are all overlapping values and therefore not statistically different
from the controls.

Although the percentages of dead and

resorbed fetuses overlap and were not significantly different from controls, a trend toward increasing embryotoxicity
with increasing

concentratio~s

of LAS administered is seen.

Also, 5 of the fetal deaths at 225 mg/kg represent retarded
growths, whereas no retarded growths were observed in the
controls or any other group.

Possible embryotoxicity a-::,

225 mg/kg is further evidenced by the number of females not
bearing litters.

None of the aforementioned signs of mater-

nal toxicity were preserit.
Although a similarly high number of non-pregnancies
is seen in the control group, they may reflect a non-random
selection of

fema~es

by the experimenter.

In these cases,

although copulation had occurred, the likelih.ood of pregnancy may have been diminished due to a decreased sperm concentration in the semen.
It should be noted that although the percentage of

......

~

TABLE III
FETAL AND LITTER PARAMETERS
DOSE
rngLAS/
kg BODY
WEIGHT

NUMBER OF DAMS
BEARING VIABLE
YOUNG/NUMBER OF
CONFIRMED PR?GNANCIES

AVEHAGE
LITTER
SIZE
± S.D.

PERCENTAGE
RESORBED AND
DEAD FETUSES
+

s.n.

AVERAGE
LITTER
WEIGHT( gm)
+ S.D.

AVERAGE
FETAL
VOLUME(ml)
+ S.D.

-

0

15/21

12.00±2.9

4.17±5.8

18.5±3.7

1.03+0.14

5

13/15

12.54+1.9

4.37±5.4

18.1+2.8

0.99+0.09

100

12/15

13.00±1.9

5.66+5.6

17.8±2.7

0.95+0.12

225

13/21

12.69+2.9

10.77±9.7

18.0±J.5

0.97+0.12

'

Presented are the fetal and litter parameters of dams in the 17 day study which received
either 0.20 ml 'LAS-vehicle or 0.20 ml vehicle alone beginning on day 0 of gestation.

I'\)
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dead and resorbed fetuses differ between control and experimental groups, all other parameters are

compar~ble.

Thus the production of anomalies in the experimental groups

r

does not appear to have been influenced by maternal factors
or diet.
The only visceral anomalies detected using Wilson's
sectioning techniques (1965) were 1 hydrocephalus (Figure
2), 2 cleft palates (Figure 4), and one case of
ing of the aortic arch.

misposition~

The 4 affected fetuses were of 110

examined in the 225 mg/kg group.

No visceral defects were

found in any of the 144 fetuses in control, 115 fetuses in
I

the 5 mg/kg, or 102 fetuses in the 100 mg/kg groups.

The

placenta of one fetus with cleft palate was fused with the
placenta of the neighboring fetus; how this may have influenced the production of the cleft is analyzed in the
discussion.

Five fetuses in the 225 and 100 mg/kg groups

exhibited underdeveloped he.arts, but it was .not clear
whether these represented miscounted fetal deaths or abnormalities; these data were not incluaed.
Results of skeletal examinations are summarized in
Table IV, which tabulated the incidence of extra ribs, unossified 5th sternebrae (Figure 6), and
of sternebrae.

incomple~e

fusion

The latter abnormality was designated as

"dumbbell shaped" (Figure 7).

The colu.."nll marked "Other"

tabulated unfused sternebrae other than the 5th.

In

assessing the skeletal anomalies, some attention must be

.-
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Figure shows a picture of a longitudinal section
through a brain suspected as having hydrocephalus.
Enlarged lateral ventricles are characteristic of
hydrocephalus.

Figure 2

Figure shows a picture of a longitudinal section
through a normal brain.

Figure 3

...

Fig.2

...

Fig. 3
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Figure shows a picture of a fetus with cleft
palate.

Figure 4

Figure shows a picture· of a nonnal palate.

Figure 5

.

..

Fig. 4

...

Fig . 5

-

TABLE IV
SKELETAL VARIATIONS
DOSE
(mg/kg)

NUMBER OF
FETUSES
EXANIINED

NUMBER OF
FETUSES
AFFECTED

PERCENTAGE
FETUSES
AFFECTED

0

31

17

54.84

12

2

5

1

5

39

18

46.15

12

2

4

2

100

38

15

39.47

6

8

0

2

225

35

13

37.14

6

4

3

2

EXTRA
RIBS

UNOSSIFIED
5th

DUMBBELL

OTHER*

SHAPED

STERNE BRAE

* Dumbbell fonnations at the second and fourth sternebrae.
The data represents the incidences of observed skeletal variations of fetuses stained
with Alizarin Red S.

N
Vt

...........
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Figure shows a picture of a fetus with no
ossification of the 5th sternebra.

Figure 6

...

. ~

Fig. 6
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Figure shows a picture of a fetus with incomplete
fusion of the 2nd and 5th sternebrae; these were
designated "dumbbell shaped".

Figure 7

....

Fig. 7

2$

paid to normal variations 'tihich occur within a population.
For example, Palrner (1972) describes extra ribs as· such a
variant with no particular significance to teratogenic
activity.

For this reason, the skeletal variations observed

do not appear to be in any way related to LAS administration.
Table V lists multiple defects and the distribution
of anomalies within groups and litters.

The purpose of this

table is to assess the occurrence of related anomalies and
litter effects.

No instances of litter effects or multiple

visceral anomalies in one fetus were found.

The occurrence

of multiple skeletal defects is due to the high incidence
of extra ribs.

Omission of these values of extra ribs

decreases the number of fetuses with multiple defects to

o.

A random distribution is seen in the number of affected
litters.
.

..

-....

TABLE V
DISTRIBUTION OF ANOMALIES
VISCERAL ANOMALIES
DOSE
(mg/kg)

NUMBER OF
FETUSES WITH
MULTIPLE
DEFECTS

NUMBER OF
AFFECTED
LITTERS/TOTAL
NUMBER OF
LITTERS

NUMBER OF LITTERS
WITH 2-3 FETUSES
WITH SAME DEFECT

NUMBER OF LITTERS
WITH 4 OR MORE
FETUSES WITH SAME
DEFECT

0

0

0/15

0

0

5

0

0/13

0

0

100

0

0/12

0

0

225

0

4/13

0

0

SKELETAL ANOMALIES
0

3

7/8

4

l* (extra ribs)

5

2

.S/11

7

0

100

1

9/11

4

0

225

2

5/10

1

l* (extra ribs)

N

'°
\

DISCUSSION
In evaluating the data for teratogenicity, the firm
establishment of nonnal incidences of malformations is required.

Data from this experiment have not provided enough

background data of frequencies of sporadic anomalies to
allow acceptable statistical analysis.

However, when com-

pared to 2.23 hydrocephalic mice per 10,000 fetuses and

45.56 mice with cleft palate per 10,000 fetuses for sporadic
incidences of anomalies (Palmer, 1972), differences to the
225 mg/kg group are observed.

Although these values may be

statistically significant, they are not teratogenically significant, since the values are low enough to be within normal limits of a population (Wilson, 1975, personal communication) and they do not stress one single defect or related
defects.

The administration of LAS may have only slightly

exceeded the threshold for these common anomalies (Fraser,
1971).

However, conclusions will be drawn later.
Making a distinction between nonnal and hydrocephalic

fetuses was quite difficult, since the development o.f the
lateral ventricles was not completed at this developmental
stage (Figures 2 and 3).

Examination o.f a representative

section of a .fetus with hydrocephalus did not confirm this
30

...

interpretation (Wilson, 1975, personal communication).

The
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scoring of cleft palate did not have this ambiguity; the
observed clefts were clear (Figures 4 and 5).

In one case

of observed cleft palate, the placentas of a malformed fetus
and its neighbor were fused.

This fusion of placentas could

have contributed to the fonnation of the cleft; a fetus with
decreased placental supply may lack the necessary metabolites for proper palatal closure (Fraser, 1971).

A similar

occurrence of placental fusion in the same litter produced
one normal and one underdeveloped fetus.
The relationship of anomalies to sex and uterine
position have been explored.

Of a total of 207 male and

204 female fetuses examined, males show a higher incidence
of anomaly than females (4 to O).

This observation sug-

gests that males exhibit a higher susceptibility toward such
anomalies than females, but lack of sufficient numbers of
affected fetuses warrants caution not to overstate this observation.

The uterine positions of abnormal fetuses in the

examined litters appeared to be random.
The mechanism of LAS action on the fetus is difficult
to ascertain.

The development of cleft palate may be in-

fluenced by a decrease of amniotic fluid which produces
clefts by overconstriction of the fetus, or a decrease in
availability of mucopolysaccharide necessary for palatal
closure (Fraser, 196g).

Overconstriction of the fetus

presses the tongue against the palatal shelves, thereby

...

preventing their union.

Mucopolysaccharides are necessary

for shelf extension and growth.
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The mechanism by which LAS

produces cleft palates depends largely on placental transfer
of the compound which has not yet been proven.

Assmning

gastro-intestinal absorption, placental transfer might result in solubilization of mucopolysaccharide.

It should be

noted that for th1.s mechanism to operate the concentrationof the surfactant must be sufficient to overcome excretion
by the kidney and oxidative degradation into products which
lack surfactant properties (Michael, 1968).
Hydrocephalus may be produced by or1e of three mechanisms: overproduction of cerebrospinal fluid (CSF), defective absorption of CSF, or obstruction of CSF drainage
(Fishman, 1971).

Little is known about the overproduction

of CSF, but defective absorption can be caused by high CSF
protein concentration which decreases the absorption
through the arachnoid villi.

Obstruction of CSF pathways

can be at the level of the ventricular aqueduct (n-:m-communica~in5

hydrocephalus) or at the level of the spinal

subarachnoid space (communicating hydrocephalus) (?oley,

1974).

Excess amounts of amniotic fluid may also play a

significant role in the formation oi' hydrocephaly (Posner,

1972).

However, since only one case of mild.hydrocephalus

was observed, discussion of the mode of action by which LAS
produces hydrocephaly appears moot.
There appear to be two periods of gestation during

...

which the embryo or fetus is most susceptible to the action
of LAS.
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One period of embryo susceptibility is seen in the

term study, in which a high number of early resorptions was
observed at 225 mg/kg.

This period is essentially the first

trimester of gestation.

Susceptibility during this time may

be due to the presence of a yolk sac placenta (Bellairs,
1971) and fetal deaths might be a result of the denaturation
of membrane or nutrient protein by LAS (Yang and Foster,
1953).

It should be noted that large concentrations of the

surfactant are not necessary for protein-surfactant complex
formation (10.5 x 10-5M).

The occurrence of fetal deaths

after early exposure of the embryo to LAS corresponds to the
observation of Manner and Dewese (1974) in fish.

Such ob-

served deaths and anomalies after early exposure to the surfactant may be related to yolk protein-surfactant complexing.
The second period of susceptibility to LAS may affect
early fetal development as illustrated by the
hydrocephalus, and retarded growths.

clef~

palates,

The critical period

for the production of cleft palate and hydrocephaly excompasses the early portion of the last trimester (Dagg, 1966;
Rugh, 1968), a time which would correspond to th_e developmental age of many of the retarded growths observad at the
225 mg/kg dose.

Although the formation of

thelial placenta
tibility to LAS may again be influenced

...
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sac placenta.
One question that can be posed at this time is why
such varying results have been reported in many mammalian
studies.

It is known that the results of any toxic or

teratogenic study are always dependent, to some extent, on
mechanical or procedural factors such as time and method of
administration of teratogen (Halberg, 1974; Haus et al.,

1974).

An important factor is the particular type of LAS

preparation tested, which can vary with respect to chain
length and positional isomeric composition from manufacturer
to manufacturer.

Variable composition may account in part

for varying levels of toxicity in mammals; such variances
have been documented in fish (Hirsch, 1963; Borstlap, 1964;
Manner and Dewese, 1974).
An equally important factor is the timing of admini-

stration, not only with respect to gestation, but also with
respect to circadian rhythm (Halberg, 1974).

It has been

reported that varying degrees of drug susceptibility are
present at different times of the circadian rhythm (Haus et
al., 1974).

Thus, the time in the animals natural rhythm

at which the dose is administered may play a significant
role in obtaining varying results.
Timing

ir1i th

influence results.

respect to the gestation period may also
For example, Palmer

~

al. ( 1975), using

methods approximating the ones employed here, gavaged ICR
CD-1 mice ·with an LAS preparation on days 6 to 15 of gesta-

.-

tion.

Deaths occurred in 19 of 20 mice at 600 mg/kg and

7 of 20 mice at JOO mg/kg.
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In the latter group·, only 9 of

the 13 surviving dams bore young.

At dosages of 2.0 and

0.2 mg/kg, no toxicity was evident in darns or their off-

spring.

Results of the present experiment indicate that

LAS administered during the first 6 days of gestation was
sufficiently toxic at levels above 225 mg/kg to interfere
with the processes leading to normal blastocyst implantati on.
The mode of administration employed in any teratogenic study often reflects actual means of exposure and
greatly influences the results.

Percutaneous studies which

assume primary exposure to the compound have shown both
positive and negative results (Sakai, 1973; Palmer, 1973).
However, absorption through the skin may be minimal in
comparison with other modes of administration (Gale, 1974).
One striking example of the effects of different modes of
administration can be seen in a comparison of oral versus
intraperitoneal administration levels; a 5 fold difference
exists in the dose of surfactant that can be tolerated for
normal implantation (David et al., 1975, manuscript submitted for review).

The cause of this difference is not known,

but several possibilities exist: metabolic inactivation of
the compound by omega- followed by beta-oxidation (Michael,

1968), a slow rate of absorption through the gastro-intestinal tract (Michael, 196$), or a combination of factors
including rate of placental transfer (Villee, 1965; Wilson,

,

..
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1973).

VJhatever the mechanism, it is evident that ex-

tremely large a.'ilou.."1.ts of oral LAS were necessary

~o

produce

effects similar to those obtained with other methods.
Conclusions
The primary question of the present research has been
to ascertain the teratogenic potential of LAS in ICR CD-1
mice.

The hypothesis that LAS is teratogenic in mice is

suggested only by the data of embryotoxicity at the 225 mg/kg
level, since fetal deaths and resorptions may represent
embryotoxicity produced by teratogenicity {Beck and Lloyd,
1963).

However, this embryotoxic activity may correspond

only to the presence of the yolk sac placenta.

The later

f onnation of the heme-endothelial placenta characteristic
of rodents apparently acts as a sufficient barrier to prevent any teratogenic activity by the surfactant.

The ob-

servation of a few common visceral defects at the 225 mg/kg
dose may reflect 1) the lower tolerance of a few dams, or
2) a nonnal incidence of defects in a population.

In

either case, the defects were not considered to be·teratogenically significant.
An underlying question, however, concerns the potential hazard to humans.

As mentioned in the introduction of

this paper, species tolerance to various compounds plays a
significant role in evaluating teratogenic potential.

Such

a problem can be illustrated by the results obtained by
Palmer~

al. (1975) in which CD rats and CD-1 mice were

intubated with comparable concentrations of LAS.

It was
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found that 600 mg/kg was lethal to 19 of 20 mice, while not
lethal to any rats.

Similarly, while JOO mg/kg had no ef-

feet on rats, 7 of 20 mice died, with 4 of the survivors
failing to bear young.

Explanations which cite the size of

the animal as the sensitivity factor were untenable, since
. NZW rabbits also used in the study showed responses to LAS
which were comparable to those obtained from mice.

Results

of a comparable nature have been reported for other compounds (Schumacher

et~.,

1972).

The effects of such

species tolerance, particularly of the rat, are secondary
to this study, but in assessing LAS teratogenicity to
humans, such resistance of a widely used test animal complicates any conclusions to be drawn from the available
data.

However, the environmental hazard of LAS to humans

appears minimal, since 1) levels of LAS in the environmental
watershed are low, due to rapid degradation by sewage

bact~

eria (Swisher, 1963; Halvorson and Isaque, 1968); 2) fairly
low levels of LAS are consumed in comparison to body weight
(Wedell, 1966; Sir1isher, 1968); and 3) any LAS.which is ingested is metabolized and excreted into the urine (Michael,

1968).

Further, the adverse effects found in mice were

-

within the theoretical teratogenic range of the compound
(Wilson, 1973), ·with the dose closest to physiological
levels demonstrating no effect.

It can only be concluded

that at levels currently found in water supplies, 11.8 LAS

38
poses no teratogenic hazard to humans.
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45
Kruskal-Wallis test
Detennination of significance of percentage of de.ad and
resorbed fetuses.
Value

Rank

Value

Rank

Value

Rank

0

12.5

0

12.5

13.33

45

0

12.5

0

12.5

13.33

45

0

12.5

6.25

25

13.33

45

0

12.5

6.66

2$

14.29

48

0

12.5

6.66

2$

15.38

49.5

0

12.5

6.66

28

15.38

49.5

0

12.5

6.66

28

25

51.5

0

12.5

6.66

28

25

51.5

0

12.5

7.14

32

28.57

53

0

12.5

7.14

32

0

12.5

7.14

32

0

12.5

7.69

36

0

12.5

7.69

36

0

12.5

7.69

36

0

12.5

7.69

36

0

12.5

7.69

36

0

12.5

8.33

39

0

12.5

9.09

40.5

0

12.5

9.09

40.5

0

12.5

11.11

42

0

12.5

13.33

45

0

12.5

13.33

45

46

Kruskal-1:lallis test (cont.)
Stun of ranks within groups.

Control

5

rng/k~

100 mg/kE;

225 mg/kg

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

12.5

2$

12.5

12.5

12.5

2$

12.5

12.5

2$

36

12.5

12.5

28

36

12.5

28

36

39

12.5

32

40.5

42

25

36

40.5

45

32

36

45

51.5

32

45

49.5

51.5

45

48

330

53

45

312.5

447.5

49.5
341
Calculation of

11

H".
341 2

12

H=

(53 )( 54)

Hadjusted

Reale

(~
H

=D

= 5.1287

i

+

.
312.5 2
330 2
447.5
3(54)
13
+ -rz- + 1)
-

D

=l

-

14202

(52)(53)(54)

Critical H (p = 0.05) = 7.815

Chi square test
Determination of significance of skeletal defects.
Control

5 mg/kg

Expected=

13.65

17.16

16.72

15.14

Observed=

17

18

15

13

Expected=

17.35

21.84

21.28

19.6

Observed=

14

21

23

22

80

Total=

31

39

38

35

143

100 mg/kg

225 mg/kg

Anomalous

Total
Observed

63

Normal

Expected Anomalous
Expected Normal
'

=~

= Total

(Total of group)

of Group - Expected Anomalous

Calculated Chi square = 2.52

Critical Chi square (p

= 0~05) = 7.815

+--

--..J
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